191 related articles for article (PubMed ID: 38106559)
1. Long-term symptom profiles after COVID-19
Vivaldi G; Pfeffer PE; Talaei M; Basera TJ; Shaheen SO; Martineau AR
EClinicalMedicine; 2023 Nov; 65():102251. PubMed ID: 38106559
[TBL] [Abstract][Full Text] [Related]
2. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M
Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.
Beale S; Yavlinsky A; Fong WLE; Nguyen VG; Kovar J; Vos T; Wulf Hanson S; Hayward AC; Abubakar I; Aldridge RW
Epidemiol Infect; 2024 May; 152():e77. PubMed ID: 38724258
[TBL] [Abstract][Full Text] [Related]
4. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
[TBL] [Abstract][Full Text] [Related]
5. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
6. Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan.
Omori T; Hanafusa M; Kondo N; Miyazaki Y; Okada S; Fujiwara T; Kuramochi J
J Thorac Dis; 2024 May; 16(5):3170-3180. PubMed ID: 38883639
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Symptoms Associated With SARS-CoV-2 Infection Among Blood Donors.
Shah MM; Spencer BR; James-Gist J; Haynes JM; Feldstein LR; Stramer SL; Jones JM; Saydah SH
JAMA Netw Open; 2024 Apr; 7(4):e245611. PubMed ID: 38587842
[TBL] [Abstract][Full Text] [Related]
8. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
[TBL] [Abstract][Full Text] [Related]
9. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
10. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
[TBL] [Abstract][Full Text] [Related]
11. Treated post-acute sequelae after COVID-19 in a German matched cohort study using routine data from 230,256 adults.
Müller D; Stengel S; Roesler M; Schillinger G; Dräther H; Günster C; Tillmanns H; Erhart M; Szecsenyi J; Merle U
Front Epidemiol; 2022; 2():1089076. PubMed ID: 38455320
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
13. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults.
Silverberg JI; Zyskind I; Naiditch H; Zimmerman J; Glatt AE; Pinter A; Theel ES; Joyner MJ; Hill DA; Lieberman MR; Bigajer E; Stok D; Frank E; Rosenberg AZ
PLoS One; 2022; 17(8):e0271310. PubMed ID: 35925904
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated with Long Covid Symptoms in an Online Cohort Study.
Durstenfeld MS; Peluso MJ; Peyser ND; Lin F; Knight SJ; Djibo A; Khatib R; Kitzman H; O'Brien E; Williams N; Isasi C; Kornak J; Carton TW; Olgin JE; Pletcher MJ; Marcus GM; Beatty AL
medRxiv; 2022 Dec; ():. PubMed ID: 36523412
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Symptoms and Identifying Biomarkers of Long COVID in People With and Without HIV: Protocol for a Remotely Conducted Prospective Observational Cohort Study.
Márquez NG; Jamal A; Johnston R; Richter EI; Gorbach PM; Vannorsdall TD; Rubin LH; Jennings C; Landay AL; Peluso MJ; Antar AAR
JMIR Res Protoc; 2023 May; 12():e47079. PubMed ID: 37104709
[TBL] [Abstract][Full Text] [Related]
16. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015395. PubMed ID: 36126225
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data.
Bello-Chavolla OY; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Fernández-Chirino L; Basile-Alvarez MR; Sánchez-Castro P; Núñez-Luna A; Antonio-Villa NE
Lancet Reg Health Am; 2024 Feb; 30():100688. PubMed ID: 38327277
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in Children.
Roge I; Smane L; Kivite-Urtane A; Pucuka Z; Racko I; Klavina L; Pavare J
Front Pediatr; 2021; 9():752385. PubMed ID: 34778143
[No Abstract] [Full Text] [Related]
20. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
